Veradigm Inc. (MDRX)
OTCMKTS · Delayed Price · Currency is USD
4.800
+0.250 (5.49%)
At close: Dec 31, 2025
Veradigm Market Cap
Veradigm has a market cap or net worth of $815.8 million as of December 31, 2025. Its market cap has decreased by -55.24% in one year.
Market Cap
815.80M
Enterprise Value
588.65M
Revenue
588.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
$4.80
Market Cap Chart
Since October 13, 2008, Veradigm's market cap has increased from 311.82M to 815.80M, an increase of 161.63%. That is a compound annual growth rate of 5.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 815.80M | -50.65% |
| Dec 31, 2024 | 1.65B | 44.24% |
| Dec 29, 2023 | 1.15B | -40.53% |
| Dec 30, 2022 | 1.93B | -14.77% |
| Dec 31, 2021 | 2.26B | -0.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 704.73M |
| Elite Pharmaceuticals | 521.06M |
| American Oncology Network | 394.40M |
| Northwest Biotherapeutics | 352.68M |
| CytoDyn | 342.85M |
| Silence Therapeutics | 298.05M |
| Nika Pharmaceuticals | 291.10M |
| OpGen | 158.42M |